Controlled human blood stage malaria infection: current status and potential applications.
about
Plasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsThe next 10 years for tuberculosis vaccines: do we have the right plans in place?Immunosignatures can predict vaccine efficacy.Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, KenyaSafety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria TransmissionTuberculosis vaccine development: Shifting focus amid increasing development challenges.Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?Recent advances in recombinant protein-based malaria vaccines.ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection.Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccinesAnalysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.Novel approaches in antimalarial drug discovery.Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation.Controlled human malaria infection.Controlled Human Malaria Infection: Applications, Advances and Challenges.A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.Transcriptomic Studies of Malaria: a Paradigm for Investigation of Systemic Host-Pathogen InteractionsControlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
P2860
Q28066456-45DBB92F-1341-4266-9F82-7E4530F4CE02Q33659150-D0CD3BFF-0F66-42B2-AA1B-0A26D17506FCQ34380788-B7FFE31E-3896-479A-8D98-4BBB22EF97FAQ35079832-C2CC9665-FE7C-4D76-9B5E-AF6B7646AB48Q35559418-B9FD17A5-4BAD-4F32-B6B4-07F7AB54F873Q36215894-D03A93E8-0338-4264-853F-763A013E9D0DQ36256304-A885B952-3358-4BC0-8302-25A75DE42524Q36391845-5E7790E5-9966-423F-84C7-4ED8FED089F2Q36394182-2B3D32C3-FE68-4B27-9DC7-402C98AE8C55Q36460499-8178AAAB-604F-481B-A69D-B9A11A9BE293Q36871970-3A3E847A-56DA-41CC-9671-D89A09A74BC7Q37149451-A10ECF2E-80AE-4695-980B-1B1B7110CDCAQ37334935-2B795F9E-25C7-4135-838E-93CA03D6A669Q37463375-55D4CD6E-B076-4FE2-A6B6-BA68CE6F0256Q37530299-68293854-EF5F-4618-8887-087BFD6ED5A9Q37641378-93B3FB62-6B51-4721-85A4-8DBC8537F5D3Q38148787-31C3EE19-FFD5-4887-B48F-F527DBE6E142Q38728601-D2FC6FEA-914E-40AB-83B0-CAF4240EF7D9Q39296506-F0A80063-5191-4094-8FB0-00E329C78DA1Q39362514-E9A18159-1BD3-420D-91C0-F7AED53874D4Q40205689-FACC8B30-035A-4655-AE76-9684335DB498Q44168331-C1EF4707-2D69-4CD7-A323-399D9652437BQ47547431-AA791E2D-50EE-4C57-A217-7FAE19FE1F78Q55106515-A4A17F31-2FEF-4577-A0A0-C8BCE9B27220Q58699135-B761A0B8-45CB-40AE-8C4B-8B7149D39404
P2860
Controlled human blood stage malaria infection: current status and potential applications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Controlled human blood stage m ...... us and potential applications.
@en
type
label
Controlled human blood stage m ...... us and potential applications.
@en
prefLabel
Controlled human blood stage m ...... us and potential applications.
@en
P2860
P1476
Controlled human blood stage m ...... us and potential applications.
@en
P2093
Christopher J A Duncan
P2860
P304
P356
10.4269/AJTMH.2012.11-0504
P407
P577
2012-04-01T00:00:00Z